SC 13G Filing

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

June 6, 2006

Accession Number

0001170022-06-000033

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →